Resultats de la cerca - Raynier Devillier
- Mostrar 1 - 17 resultats de 17
-
1
-
2
-
3
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hema... per Roberto Crocchiolo, Benjamin Esterni, Luca Castagna, Sabine Fürst, Jean El Cheikh, Raynier Devillier, Angéla Granata, Claire Oudin, Boris Calmels, Christian Chabannon, Réda Bouabdallah, Norbert Vey, Didier Blaise
Publicat 2012Artigo -
4
Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding... per Raynier Devillier, Diane Coso, Luca Castagna, I. Brenot Rossi, A. Anastasia, Arturo Chiti, Ivanov Vv, Jean‐Marc Schiano de Colella, Armando Santoro, Christian Chabannon, Monica Balzarotti, Didier Blaise, Réda Bouabdallah
Publicat 2012Artigo -
5
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relaps... per Jacopo Mariotti, Raynier Devillier, Stéfania Bramanti, Barbara Sarina, Sabine Fürst, Angéla Granata, Catherine Faucher, Samia Harbi, Lucio Morabito, Christian Chabannon, Carmelo Carlo‐Stella, Réda Bouabdallah, Armando Santoro, Didier Blaise, Luca Castagna
Publicat 2017Artigo -
6
Killer Cell Immunoglobulin-Like Receptor–Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Und... per Anne Wanquet, Stéfania Bramanti, Samia Harbi, Sabine Fürst, Faézeh Legrand, Catherine Faucher, Angela Granata, Boris Calmels, Claude Lemarié, Christophe Picard, Christian Chabannon, Pierre‐Jean Weiller, Luca Castagna, Didier Blaise, Raynier Devillier
Publicat 2017Artigo -
7
Role of<i>ASXL1</i>and<i>TP53</i>mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes per Raynier Devillier, Véronique Mansat‐De Mas, Véronique Gelsi‐Boyer, Cécile Demur, Anne Murati, Jill Corre, Thomas Prébet, Sarah Bertoli, Mandy Brecqueville, Christine Arnoulet, Christian Récher, Norbert Vey, Julien Mozziconacci, Éric Delabesse, Daniel Birnbaum
Publicat 2015Artigo -
8
Haploidentical T Cell–Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Ste... per Didier Blaise, Sabine Fürst, Roberto Crocchiolo, Jean El Cheikh, Angéla Granata, Samia Harbi, Réda Bouabdallah, Raynier Devillier, Stéfania Bramanti, Claude Lemarié, Christophe Picard, Christian Chabannon, Pierre Jean Weiller, Catherine Faucher, Bilal Mohty, Norbert Vey, Luca Castagna
Publicat 2015Artigo -
9
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity per P Bernard, Rebecca B. Delconte, Sonia Pastor, Vladimir Laletin, Cathy Costa Da Silva, Armelle Goubard, Emmanuelle Josselin, Rémy Castellano, Adrien Krug, Julien Vernerey, Raynier Devillier, Daniel Olive, Els Verhoeyen, Éric Vivier, Nicholas D. Huntington, Jacques A. Nunès, Geoffrey Guittard
Publicat 2022Artigo -
10
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer per Philippe Rochigneux, Aaron Lisberg, Alejandro J. Garcia, Samuel Granjeaud, Anne Madroszyk, Stéphane Fattori, Anthony Gonçalvès, Raynier Devillier, Pauline Maby, N. Salem, Laurent Gorvel, Brice Chanez, Jaklin Gukasyan, James Carroll, Jonathan W. Goldman, Anne-Sophie Chrétien, Daniel Olive, Edward B. Garon
Publicat 2022Artigo -
11
Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma per Luca Castagna, Stéfania Bramanti, Raynier Devillier, Barbara Sarina, Roberto Crocchiolo, Sabine Fürst, Jean El Cheikh, Angéla Granata, Catherine Faucher, Samia Harbi, Lucio Morabito, Jacopo Mariotti, Sairaj Puvinathan, Pierre Jean Weiller, Christian Chabannon, Djamel Mokart, Carmelo Carlo‐Stella, Réda Bouabdallah, Armando Santoro, Didier Blaise
Publicat 2017Artigo -
12
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML per Anne-Sophie Chrétien, Raynier Devillier, Cyril Fauriat, Florence Orlanducci, Samia Harbi, Aude Le Roy, Jérôme Rey, Gaelle Bouvier Borg, Emmanuel Gautherot, Jean-François Hamel, Norbert Ifrah, Catherine Lacombe, Pascale Cornillet‐Lefèbvre, Jacques Delaunay, Antoine Toubert, Christine Arnoulet, Norbert Vey, Didier Blaise, Daniel Olive
Publicat 2017Artigo -
13
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leuke... per Raynier Devillier, Faézeh Legrand, Jérôme Rey, Luca Castagna, Sabine Fürst, Angéla Granata, Aude Charbonnier, Samia Harbi, Evelyne D’Incan, Thomas Pagliardini, Catherine Faucher, Claude Lemarié, Colombe Saillard, Boris Calmels, Bilal Mohty, Valério Maisano, Pierre‐Jean Weiller, Christian Chabannon, Norbert Vey, Didier Blaise
Publicat 2018Artigo -
14
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing per Sumin Jo, Shipra Das, Alan F. Williams, Anne-Sophie Chrétien, Thomas Pagliardini, Aude Le Roy, Jorge Postigo, Diane Le Clerre, Billal Jahangiri, Isabelle Chion-Sotinel, Sandra Rozlan, Emilie Dessez, Agnès Gouble, Mathilde Dusséaux, Román Galetto, Aymeric Duclert, Emanuela Marcenaro, Raynier Devillier, Daniel Olive, Philippe Duchâteau, Laurent Poirot, Julien Valton
Publicat 2022Artigo -
15
Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Seve... per Raynier Devillier, J-H Dalle, Austin Kulasekararaj, Maud D’Aveni, Laurence Clément, Alicja Chybicka, S. Vigouroux, Patrice Chevallier, Mickey Koh, Y. Bertrand, M. Michallet, Marco Zecca, Ibrahim Yakoub‐Agha, Jean‐Yves Cahn, Petter Ljungman, Marc Bernard, Philippe M. Loiseau, Valérie Dubois, Sébastien Maury, Gerard Socié, Carlo Dufour, Régis Peffault de Latour
Publicat 2016Artigo -
16
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome per Anne-Sophie Chrétien, Raynier Devillier, Samuel Granjeaud, Charlotte Cordier, Clémence Demerle, N. Salem, Julia Wlosik, Florence Orlanducci, Laurent Gorvel, Stéphane Fattori, Marie‐Anne Hospital, Jihane Pakradouni, Emilie Gregori, Magali Paul, Philippe Rochigneux, Thomas Pagliardini, Mathieu Morey, Cyril Fauriat, Nicolas Dulphy, Antoine Toubert, Hervé Luche, Marie Malissen, Didier Blaise, Jacques A. Nunès, Norbert Vey, Daniel Olive
Publicat 2021Artigo -
17
Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio per Jurjen Versluis, Florentien E. M. in ’t Hout, Raynier Devillier, Wim L.J. van Putten, Markus G. Manz, Marie‐Christiane Vekemans, M -C Legdeur, Jakob Passweg, Johan Maertens, Jürgen Kuball, Bart J. Biemond, Peter J.M. Valk, Bert A. van der Reijden, Giovanna Meloni, Harry C. Schouten, Edo Vellenga, Thomas Pabst, Roel Willemze, Bob Löwenberg, G.J. Ossenkoppele, Frédéric Baron, Gerwin Huls, Jan J. Cornelissen
Publicat 2016Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Transplantation
Biology
Immunology
Oncology
Cancer research
Chemotherapy
Gastroenterology
Gene
Myeloid leukemia
Physics
Cumulative incidence
Genetics
Hematopoietic stem cell transplantation
Incidence (geometry)
Optics
Surgery
Cyclophosphamide
Bone marrow
Confidence interval
Graft-versus-host disease
Hazard ratio
Immune system
Myeloid
Biochemistry
Cytotoxic T cell
Flow cytometry
In vitro
Leukemia